NASDAQ · Drug Manufacturers - Specialty & Generic

CRDL (CRDL) Stock

$1.36 +1.49% NASDAQ: CRDL Healthcare

Valuation

MetricValue
Price$1.36
Market Cap$156.77M
P/E Ratio-3.38
P/B Ratio8.20
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$1.71
52-Week Low$0.88
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-188.89%
ROA-141.67%
ROCE-188.89%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio4.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-31.0M$-30.0M$-22.0M$-40.0M$-34.0M
Net Profit$-25.0M$-23.0M$-21.0M$-37.0M$-34.0M
EPS$-0.73$-0.49$-0.44$-0.51$-0.39
Op Margin-49092.4%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$88.0M$46.0M$37.0M$32.0M$24.0M
Total Liabilities$12.0M$7.0M$8.0M$7.0M$6.0M
Cash$84.0M$44.0M$35.0M$31.0M$21.0M
Borrowings$0$0$0$0$0

Latest News

Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association CNW Group · Jul 14, 2026 Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit PR Newswire · Jul 9, 2026 Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders PR Newswire · Jun 25, 2026 Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT CNW Group · Jun 23, 2026 Here's Why We're Watching Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation Simply Wall St. · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-24.0M$-27.0M$-25.0M$-25.0M$-24.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$9.0M$0$0$-2.0M$0
Net Cash Flow$70.0M$-24.0M$-25.0M$-4.0M$-9.0M
Free Cash Flow$-24.0M$-27.0M$-25.0M$-25.0M$-24.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-11.73%
Quick Ratio4.39
Interest Coverage—
Return 1Y-13.53%
Return 3Y41.28%
Return 5Y-48.20%

Ownership

Insiders Held2.38%
Institutions Held24.67%
Institutions Float Held25.27%
Institutional HolderSharesReport Date
MMCAP International, Inc. SPC15,352,3172026-03-31
Tejara Capital Ltd5,130,1222026-03-31
Ikarian Capital, LLC2,725,0002026-03-31
Citadel Advisors Llc819,9042026-03-31
Boothbay Fund Management, LLC794,8812026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About CRDL

CRDL is led by CEO David G. Elsley, employs 18 people, headquartered in CA, publicly traded since 2019.

CRDL stock trades at $1.36 with a market capitalization of $156.77M. The stock is valued at a price-to-earnings (P/E) ratio of -3.38, price-to-book of 8.20, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.88 and $1.71, and currently trades 20.5% below its 52-week high.

On profitability, CRDL generates a return on equity (ROE) of -188.89%, return on capital employed of -188.89%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides